Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers
Active Cooperative Agreement Awarded Last action
- Award ID
- U01FD008299
- Recipient
-
Sloan-Kettering Institute For Cancer Research UEI KUKXRCZ6NZC2
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $1,496,492
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 72% complete
- Funding agency
- Office of the Commissioner Food and Drug Administration, Department of Health and Human Services
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
About this award
This Cooperative Agreement award from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) provides $1,496,492.00 to the Sloan-Kettering Institute for Cancer Research to conduct research on elucidating tumor-specific cell surface proteomes in ultra-rare cancers like rhabdoid tumors and desmoplastic small round cell tumors. The goal is to gain a better understanding of these challenging, therapy-resistant cancers and identify potential new therapeutic targets. The project, which runs from September 2024 to August 2027, will leverage integrative proteogenomic approaches to characterize the unique cell surface protein profiles of these ultra-rare sarcomas. The Sloan-Kettering Institute, a prominent non-profit cancer research organization, has extensive experience in conducting federally-funded research across various oncology domains.
Description
- Abstract
- Despite advances in treatment, sarcomas like rhabdoid tumors and desmoplastic small round cell tumors (dsrct) remain challenging, with frequent therapy resistance and fatal outcomes. The rarity of these cancers (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,496,492 |
Quick answers
Who received award U01FD008299?
U01FD008299 was awarded to Sloan-Kettering Institute For Cancer Research by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 5, 2024.
How much is award U01FD008299 worth?
$1,496,492 has been obligated on U01FD008299.
Which agency awarded U01FD008299?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U01FD008299, with funding from Office of the Commissioner (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award